Fraser Health is taking part in the first full clinical trials of a C. difficile (C. diff) vaccine at the Royal Columbian and Surrey Memorial Hospitals.
C.diff is an infection caused by spore-forming bacterium called Clostridium difficile, which is a contributing factor in the deaths of more than 2,000 Canadians. The vaccine attacks the toxins that damage the bowel, and early data indicates the vaccine may produce a positive response from the body to fight off the infection, even in the elderly.
Individuals that are expected to be in hospital over the next 60 days, and are scheduled for special types of surgery, will be contacted to participate in the trial. In addition, patients who have been in hospital at least twice over the last 12 months and have taken antibiotics will also be recruited for this trial.
Fraser Health will work collaboratively with its medical partners to enlist participants and provide individuals with an opportunity to volunteer.
The trial will begin towards the end of August and will continue for 30 months. In the meantime, Fraser Health will continue to maintain strict cleaning protocols throughout its facilities, and remind patients, visitors and staff to practice vigorous hand hygiene.
For more information about the trial, or to participate, please call 1-855-587-7889 or visit www.Cdiffense.org.
© Copyright 2013